Yes you are able to purchase Saxenda, Wegovy or Mounjaro from us without having to join a bespoke plan. We conduct a detailed health screening for anyone interested in buying medication to make sure it's suitable for you. Once a doctor has approved you for the medication, you can make the payment and we will get it delivered to you via a UK licensed partner pharmacy.

As we believe that medication without any support will not be beneficial for our patients, we offer a medication only package which includes our Simplyweight Online Plan for additional support. This includes home workouts, weight and stats tracking, portion guidance, medical weight loss resources and lessons, guided meditations and more.

In addition, we have our medication support plans for those looking for further support alongside their weight loss medication. 

To request a medication please, click here to fill out our health screening form 

Saxenda works similar to an appetite regulating hormone that the body produces naturally, known as Glucagon-Like-Peptide (GLP-1). Saxenda is the trade name for a generic drug, which has been used for the management for Type 2 diabetes for more than 10 years. It works by activating areas of the brain that regulate appetite, thereby makes you feel less hungry.

Research shows that Saxenda is effective only if supported by long-term lifestyle changes.

Wegovy® is a prescription medication that is used to help adults with obesity or overweight lose weight and keep it off. It is a once-weekly injection that works by mimicking the action of a gut hormone called GLP-1. GLP-1 helps to control appetite and make you feel full after eating. Wegovy® also helps to slow down the movement of food through your digestive system, which can help you feel full for longer.

Wegovy® was approved by the FDA in June 2021 for the treatment of obesity in adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

Mounjaro® (tirzepatide) is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is a dual-acting incretin mimetic that works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). GIP and GLP-1 help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.

Mounjaro® has been shown to be effective in promoting weight loss in adults with type 2 diabetes and obesity. In one study, patients who took Mounjaro® for 84 weeks had an average weight loss of 10.2kg, compared with a weight loss of 1.2kg in patients who took a placebo.